Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/j.1365-2702.2012.04081.x | DOI Listing |
N Engl J Med
December 2023
Hôpital Saint-Antoine Assistance Publique-Hôpitaux de Paris, Paris, France
Lancet
November 2023
Center for Bioethics and Humanities, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Importance: Left ventricular assist devices (LVADs) enhance quality and duration of life in advanced heart failure. The burden of nonsurgical bleeding events is a leading morbidity. Aspirin as an antiplatelet agent is mandated along with vitamin K antagonists (VKAs) with continuous-flow LVADs without conclusive evidence of efficacy and safety.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!